Verucerfont
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
| 100mg | Ikhona evenkileni | 700 |
| Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
(S) -3-(4-methoxy-2-methylphenyl) -2,5-dimethyl-N-(1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl)pyrazolo[1, 5-a]pyrimidin-7-amine
Ikhowudi yoncumo:
CC[C@H](NC1=CC(C)=NC2=C(C3=CC=C(OC)C=C3C)C(C)=NN12)C4=NC(C)=NO4
Ikhowudi ye-InChi:
InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14) (4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/ s1
Isitshixo se-InChi:
VKHVAUKFLBBZFJ-SFHVURJKSA-N
Igama elingundoqo:
Verucerfont, GSK561679, GSK 561679, GSK-561679, NBI77860, NBI 77860, NBI-77860, 885220-61-1
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
"I-Verucerfont, eyaziwa ngokuba yi-GSK561679 kunye ne-NBI77860, ngumchasi we-CRF-1. I-Verucerfont ivimbela i-receptor ye-CRH-1, kwaye ngoko iyanciphisa ukukhululwa kwe-ACTH emva koxinzelelo olungapheliyo. Kuphandwa njengonyango olunokubakho kutywala, njengoko uxinzelelo olungapheliyo luhlala lukhona. into ekuphuhlisweni kotywala kunye nokubuyela ekubuyiseleni izinxila Ibonise iziphumo ezithembisayo kwizifundo zezilwanyana kodwa ayizange ihlolwe ebantwini.
Ithagethi: CRF-1